Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody.
Jacobson, Jeffrey M.; Thompson, Melanie A.; Lalezari, Jacob P.; Saag, Michael S.; Zingman, Barry S.; D'Ambrosio, Paul; Stambler, Nancy; Rotshteyn, Yakov; Marozsan, Andre J.; Maddon, Paul J.; Morris, Stephen A.; Olson, William C.; Journal of Infectious Diseases, 2010, vol. 201, issue 10, p 1481, ISSN 00221899. ISBN 15376613.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef